|Other Names||Tripartite motif-containing protein 34, Interferon-responsive finger protein 1, RING finger protein 21, TRIM34, IFP1, RNF21|
|Target/Specificity||The synthetic peptide sequence used to generate the antibody AP13644a was selected from the N-term region of TRIM34. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.|
|Format||Synthetic peptide was lyophilized with 100% acetonitrile and is supplied as a powder. Reconstitute with 0.1 ml DI water for a final concentration of 1 mg/ml.|
|Storage||Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C.|
|Precautions||This product is for research use only. Not for use in diagnostic or therapeutic procedures.|
|Tissue Location||Isoform 1 is the most abundant form. It is highly expressed in the placenta, spleen, colon and peripheral blood leukocytes.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
The protein encoded by this gene is a member of thetripartite motif (TRIM) family. The TRIM motif includes threezinc-binding domains, a RING, B-box type 1 and B-box type 2 domain,and a coiled-coil region. Expression of this gene is up-regulatedby interferon. This gene is mapped to chromosome 11p15, where itresides within a TRIM gene cluster. Alternative splicing results inmultiple transcript variants. A read-through transcript from theupstream TRIM6 gene has also been observed, which results in afusion product from these neighboring family members. [provided byRefSeq].
Sawyer, S.L., et al. PLoS Pathog. 3 (12), E197 (2007) :Li, X., et al. Virology 360(2):419-433(2007)Zhang, F., et al. Virology 353(2):396-409(2006)Li, X., et al. J. Virol. 80(13):6198-6206(2006)Reymond, A., et al. EMBO J. 20(9):2140-2151(2001)
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.